The Scandal of Our Drug Supply

Katherine Eban’s disquieting, often unnerving, and at times infuriating new book Bottle of Lies ranges across the pharmaceutical industry in several countries, but its chief concern is the generic drug industry in India and the inconsistent vetting by the FDA of the industry’s products for the American market. The FDA’s lack of rigorous, uniform scrutiny of imported pharmaceuticals has put the prescription drug supply in the United States at risk from contaminated, ineffective, and even fraudulent medications—products that not only might fail to control disease but might themselves be life-threatening.

The New York Review of Books